Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
about
Modulation of osteoclastogenesis with macrophage M1- and M2-inducing stimuliInflammation as a contributing factor among postmenopausal Saudi women with osteoporosisCapric acid inhibits NO production and STAT3 activation during LPS-induced osteoclastogenesis.Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis.Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesisOsteoclasts lose innate inflammatory reactivity to metal and polymer implant debris compared to monocytes/macrophages.Effects of Porphyromonas gingivalis lipopolysaccharide on osteoblast-osteoclast bidirectional EphB4-EphrinB2 signalingChemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.uPA Attenuated LPS-induced Inflammatory Osteoclastogenesis through the Plasmin/PAR-1/Ca(2+)/CaMKK/AMPK Axis.Enterococcus faecalis promotes osteoclastogenesis and semaphorin 4D expression.Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo.Effects of ibandronate sodium, a nitrogen-containing bisphosphonate, on intermediate-conductance calcium-activated potassium channels in osteoclast precursor cells (RAW 264.7).Involvement of redox balance in in vitro osteoclast formation of RAW 264.7 macrophage cells in response to LPS.Lipopolysaccharide (LPS) induces the apoptosis and inhibits osteoblast differentiation through JNK pathway in MC3T3-E1 cells.Evidence for mitoxantrone-induced block of inwardly rectifying K(+) channels expressed in the osteoclast precursor RAW 264.7 cells differentiated with lipopolysaccharide.Seladin-1 is a novel lipopolysaccharide (LPS)-responsive gene and inhibits the tumour necrosis factor-alpha production and osteoclast formation in response to LPS.Concanavalin A induces formation of osteoclast-like cells in RAW 264.7 mouse macrophage cells.Release of prostaglandin E(1) from N-(2-hydroxypropyl)methacrylamide copolymer conjugates by bone cellsEffect of Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on the expression of EphA2 in osteoblasts and osteoclasts.The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathwayAlexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.uPA-derived peptide, Å6 is involved in the suppression of lipopolysaccaride-promoted inflammatory osteoclastogenesis and the resultant bone loss.Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide.LPS promotes pre-osteoclast activity by up-regulating CXCR4 via TLR-4.Lysophosphatidic acid stimulates osteoclast fusion through OC-STAMP and P2X7 receptor signaling.Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.Toxicity and bioactivity of cobalt nanoparticles on the monocytes.Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.The effect of cathepsin K inhibitor on osteoclastic activity compared to alendronate and enamel matrix protein.Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway.Modulation of Osteoclast Interactions with Orthopaedic Biomaterials.
P2860
Q27315989-72BC020C-80DC-427D-9775-0077D3950226Q28817706-9FFEB6C6-B48D-4D41-A59C-2EA4CE7D7B15Q34081790-90021486-B5E0-46F2-BEA1-5C834E386C29Q36244303-0DF3C028-C022-4CFF-944D-C46C4DBFF7EBQ37169549-B95B2C9C-8805-4F1A-A6B8-8F9139E21467Q37267293-DC3CCBCB-35B0-40DB-B6E7-57FC06177EB7Q37387637-C326EB94-D859-4DBC-8334-04F90650D6DEQ37464897-9841DB32-E396-4C08-B492-D4255209D56EQ38807300-B43F065D-BBC7-4432-AE5D-5FE69056EF0FQ38857186-8966DB63-1659-41E1-9AB8-67B027248996Q38907613-93C580D9-2B47-4A33-87E5-38ACA92473CAQ38943421-D2EA94C5-03B5-4160-B174-D3DE1F6D5F10Q39018581-53A1635C-57BE-4EE2-9978-9D6118BDC1B5Q39056110-C46DBFBB-A36E-4750-8AB5-08590ABF22F2Q39304006-420FB1E5-D1A8-4F8F-963B-C606228994F8Q39712801-A99B425F-8D67-42F7-B3B5-03A473681857Q39880900-3194B9BF-47DC-4EB9-A5D8-93782294E010Q39993395-8EC27226-64F2-4012-AC00-9266771EA7D5Q40332591-400A3FD8-6EB9-49D3-BA4E-9B9ED3A8FBE5Q40972086-E8ED31B2-11D5-43CE-AE24-3528C32E83DFQ41003979-0049E1E6-D188-407D-85D1-1A693B164338Q41506215-3B943E22-EC41-42BB-A57A-0FBFA70AE0B6Q42484433-30C2291A-AB5A-4889-94A8-2FD73C94EBA7Q42815392-E0B0E69B-16E6-4F80-961E-D7C8AC923243Q51035107-2001CA39-9BE8-4505-8FAD-B4AB758925BAQ52718664-39A701D4-B255-450C-8654-76D26818FDCBQ53481789-D1B9BB33-8DC9-4A9C-A2D3-B1570A1F6F87Q53698184-8BA537E6-BED7-43B7-9973-B3E8015423DEQ54185201-8D56D3AA-B0AB-45E6-A7BA-AF03A7806685Q54286064-ECD77E91-71DC-4C0C-B7D3-AA34A639B61AQ55006443-25DD8E21-F529-478D-98FD-FE15F1ACD1E0Q55111648-2CF6C669-FF8B-4B02-AA3C-97EC0E5ADDF8
P2860
Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
@en
type
label
Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
@en
prefLabel
Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
@en
P2093
P1476
Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
@en
P2093
Ferdaus Hassan
Gantsetseg Tumurkhuu
Isamu Mori
Jargalsaikhan Dagvadorj
Naoki Koide
Shamima Islam
Takashi Yokochi
Tomoaki Yoshida
Yoshikazu Naiki
P304
P356
10.1016/J.BBRC.2007.06.023
P577
2007-06-12T00:00:00Z